AUROPHARMA taking support on monthly trend line and 20 dma

its attempt to cross target 1 getting rejected.
with no negative news
if crosses target 1 target 2 and target 3
possible.

Yorum:

usa decision to reduce drug prices may have negative impact.
little bad news for pharma companies.